Haruhiko Machida

Prof. Dr. Haruhiko Machida


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in Radiation Medicine
Verified
Journal Article
Closed access
PDF file
HMHaruhiko Machida
Haruhiko Machida
EUEiko Ueno
Eiko Ueno
Shunichi ShiozawaShunichi Shiozawa
Shunichi Shiozawa
MFMikihiko Fujimura
Mikihiko Fujimura
ATAkira Tsuchiya
Akira Tsuchiya
MAMotohiko Aiba
Motohiko Aiba

1 January 2010 in Circulation Journal
Verified
Journal Article
Open access
PDF file
SNShinichi Nunoda
Shinichi Nunoda
HMHaruhiko Machida
Haruhiko Machida
ASAkihiko Sekikawa
Akihiko Sekikawa
KSKazunobu Shitakura
Kazunobu Shitakura
KOKiyotaka Okajima
Kiyotaka Okajima
KOKuniaki Otsuka
Kuniaki Otsuka
Background: Cardiac allograft vasculopathy (CAV) is a major complication that limits the long-term survival of recipients of heart transplants. In the present study the feasibility of 2 noninvasive approaches for detecting CAV (multidetector computed tomography (MDCT) and whole-heart magnetic resonance coronary angiography (MRCA)) was compared with conventional coronary angiography (CCAG). Methods and Results: Of 22 heart transplant recipients who underwent CCAG screening, 13 had only MDCT, 16 had only MRCA, and 7 had both noninvasive modalities. The coronary arterial tree was divided into 9 segments. Detection of vasculopathy by coronary segments was compared between 16-/64-detector computed tomography (CT) or MRCA and CCAG. The sensitivity of both 16- and 64-detector CT for diagnosing CAV was 69.6%, and specificity was 96.8%. The sensitivity and specificity by 64-detector CT alone were 90.0% and 97.5%, respectively; its positive and negative predictive values were 81.8% and 98.7% respectively. For MRCA, sensitivity was 60%, specificity, 100%, positive predictive value, 100% and negative predictive value, 92.2%. MRCA showed no false positives. Conclusions: MDCT, especially 64-detector CT, is feasible for detecting CAV, whereas MRCA currently shows limited sensitivity. (Circ J 2010; 74: 946 - 953)

1 January 2018 in Circulation Journal
Verified
Journal Article
Open access
PDF file
YHYasuki Hen
Yasuki Hen
ATAyako Takara
Ayako Takara
NINobuo Iguchi
Nobuo Iguchi
YUYuko Utanohara
Yuko Utanohara
KTKunihiko Teraoka
Kunihiko Teraoka
TYTsutomu Yoshikawa
Tsutomu Yoshikawa
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies


12 May 2022 in European Radiology
Verified
Journal Article
Open access
PDF file
MWMasanaka Watanabe
Masanaka Watanabe
STSatoru Taguchi
Satoru Taguchi
HMHaruhiko Machida
Haruhiko Machida
MTMitsuhiro Tambo
Mitsuhiro Tambo
YTYuhei Takeshita
Yuhei Takeshita
KYKenichi Yokoyama
Kenichi Yokoyama
Objectives: To develop a modified Vesical Imaging Reporting and Data System (VI-RADS) without dynamic contrast-enhanced imaging (DCEI), termed “non-contrast-enhanced VI-RADS (NCE-VI-RADS)”, and to assess the additive impact of denoising deep learning reconstruction (dDLR) on NCE-VI-RADS. Methods: From January 2019 through December 2020, 163 participants who underwent high-gradient 3-T MRI of the bladder were prospectively enrolled. In total, 108 participants with pathologically confirmed bladder cancer by transurethral resection were analyzed. Tumors were evaluated based on VI-RADS (scores 1–5) by two readers independently: an experienced radiologist (reader 1) and a senior radiology resident (reader 2). Conventional VI-RADS assessment included all three imaging types (T2-weighted imaging [T2WI], diffusion-weighted imaging [DWI], and dynamic contrast-enhanced imaging [DCEI]). Also evaluated were NCE-VI-RADS comprising only non-contrast-enhanced imaging types (T2WI and DWI), and “NCE-VI-RADS with dDLR” comprising T2WI processed with dDLR and DWI. All systems were assessed using receiver-operating characteristic curve analysis and simple and/or weighted κ statistics. Results: Muscle invasion was identified in 23/108 participants (21%). Area under the curve (AUC) values for diagnosing muscle invasion were as follows: conventional VI-RADS, 0.94 and 0.91; NCE-VI-RADS, 0.93 and 0.91; and “NCE-VI-RADS with dDLR”, 0.96 and 0.93, for readers 1 and 2, respectively. Simple κ statistics indicated substantial agreement for NCE-VI-RADS and almost perfect agreement for conventional VI-RADS and “NCE-VI-RADS with dDLR” between the two readers. Conclusion: NCE-VI-RADS achieved predictive accuracy for muscle invasion comparable to that of conventional VI-RADS. Additional use of dDLR improved the diagnostic accuracy of NCE-VI-RADS. Key Points: • Non-contrast-enhanced Vesical Imaging Reporting and Data System (NCE-VI-RADS) was developed to avoid risk related to gadolinium-based contrast agent administration. • NCE-VI-RADS had predictive accuracy for muscle invasion comparable to that of conventional VI-RADS. • The additional use of denoising deep learning reconstruction (dDLR) might further improve the diagnostic accuracy of NCE-VI-RADS.

19 November 2014 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
KMKazuhiro Matsui
Kazuhiro Matsui
HMHaruhiko Machida
Haruhiko Machida
TMTetsuya Mitsuhashi
Tetsuya Mitsuhashi
HOHisako Omori
Hisako Omori
TNTakashi Nakaoka
Takashi Nakaoka
EUEiko Ueno
Eiko Ueno